Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Wegovy (Semaglutide for Obesity Treatment): Wegovy is the brand name for semaglutide, specifically formulated and approved for obesity treatment
dosing is weight-based at approximately 15-30 mcg/kg
Arenas et al
For weight management, NICE (TA664) recommends these medications within specialist weight management services for people with a BMI of at least 35 kg/m (or 32.5 kg/m in people from minority ethnic backgrounds) with non-diabetic hyperglycaemia and a high risk of cardiovascular disease, or a BMI of at least 30 kg/m with type 2 diabetes
Semaglutide must be discontinued if pregnancy occurs or at least 2 months before a planned pregnancy
Additionally, the Wegovy injection appears to be slightly more effective for weight loss than the Wegovy pill
US$ 21.34
US$ 26.83
US$ 20.74
